Interuniversity Center of Phlebolymphology (CIFL), International Research and Educational Program in Clinical and Experimental Biotechnology", Catanzaro, Italy.
Department of Medical and Surgical Sciences, University of Catanzaro, Catanzaro, Italy.
Int Wound J. 2020 Aug;17(4):987-991. doi: 10.1111/iwj.13360. Epub 2020 Apr 13.
Peripheral arterial disease (PAD) and its most severe form, critical limb ischaemia (CLI), are very common clinical conditions related to atherosclerosis and represent the major causes of morbidity, mortality, disability, and reduced quality of life (QoL), especially for the onset of ischaemic chronic leg ulcers (ICLUs) and the subsequent need of amputation in affected patients. Early identification of patients at risk of developing ICLUs may represent the best form of prevention and appropriate management. In this study, we used a Prediction System for Chronic Leg Ulcers (PredyCLU) based on fuzzy logic applied to patients with PAD. The patient population consisted of 80 patients with PAD, of which 40 patients (30 males [75%] and 10 females [25%]; mean age 66.18 years; median age 67.50 years) had ICLUs and represented the case group. Forty patients (100%) (27 males [67.50%] and 13 females [32.50%]; mean age 66.43 years; median age 66.50 years) did not have ICLUs and represented the control group. In patients of the case group, the higher was the risk calculated with the PredyCLU the more severe were the clinical manifestations recorded. In this study, the PredyCLU algorithm was retrospectively applied on a multicentre population of 80 patients with PAD. The PredyCLU algorithm provided a reliable risk score for the risk of ICLUs in patients with PAD.
外周动脉疾病(PAD)及其最严重的形式,即严重肢体缺血(CLI),是与动脉粥样硬化相关的非常常见的临床病症,代表了发病率、死亡率、残疾和生活质量(QoL)降低的主要原因,特别是对于缺血性慢性腿部溃疡(ICLU)的发病和随后受影响患者的截肢需求。早期识别有发生 ICLU 风险的患者可能是最好的预防和适当管理形式。在这项研究中,我们使用了基于模糊逻辑的用于 PAD 患者的慢性腿部溃疡预测系统(PredyCLU)。患者人群包括 80 名 PAD 患者,其中 40 名患者(30 名男性[75%]和 10 名女性[25%];平均年龄 66.18 岁;中位数年龄 67.50 岁)患有 ICLU,代表病例组。40 名患者(100%)(27 名男性[67.50%]和 13 名女性[32.50%];平均年龄 66.43 岁;中位数年龄 66.50 岁)没有 ICLU,代表对照组。在病例组患者中,用 PredyCLU 计算出的风险越高,记录的临床表现越严重。在这项研究中,PredyCLU 算法被回顾性地应用于 80 名 PAD 患者的多中心人群。PredyCLU 算法为 PAD 患者的 ICLU 风险提供了可靠的风险评分。